These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 20709564)

  • 1. The chemokine network, a newly discovered target in high grade gliomas.
    Domanska UM; Kruizinga RC; den Dunnen WF; Timmer-Bosscha H; de Vries EG; Walenkamp AM
    Crit Rev Oncol Hematol; 2011 Aug; 79(2):154-63. PubMed ID: 20709564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemokine-directed migration of tumor-inhibitory neural progenitor cells towards an intracranially growing glioma.
    Honeth G; Staflin K; Kalliomäki S; Lindvall M; Kjellman C
    Exp Cell Res; 2006 May; 312(8):1265-76. PubMed ID: 16434036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemokines and glioma: invasion and more.
    Sciumè G; Santoni A; Bernardini G
    J Neuroimmunol; 2010 Jul; 224(1-2):8-12. PubMed ID: 20656128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of CXC chemokine receptors 1-5 and their ligands in human glioma tissues: role of CXCR4 and SDF1 in glioma cell proliferation and migration.
    Bajetto A; Barbieri F; Dorcaratto A; Barbero S; Daga A; Porcile C; Ravetti JL; Zona G; Spaziante R; Corte G; Schettini G; Florio T
    Neurochem Int; 2006 Oct; 49(5):423-32. PubMed ID: 16621164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Manipulating the chemokine-chemokine receptor network to treat cancer.
    Ruffini PA; Morandi P; Cabioglu N; Altundag K; Cristofanilli M
    Cancer; 2007 Jun; 109(12):2392-404. PubMed ID: 17503430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemokine receptors in the central nervous system: role in brain inflammation and neurodegenerative diseases.
    Cartier L; Hartley O; Dubois-Dauphin M; Krause KH
    Brain Res Brain Res Rev; 2005 Feb; 48(1):16-42. PubMed ID: 15708626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autocrine factors that sustain glioma invasion and paracrine biology in the brain microenvironment.
    Hoelzinger DB; Demuth T; Berens ME
    J Natl Cancer Inst; 2007 Nov; 99(21):1583-93. PubMed ID: 17971532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the erythropoietin receptor on glioma cells reduces tumour growth.
    Pérès EA; Valable S; Guillamo JS; Marteau L; Bernaudin JF; Roussel S; Lechapt-Zalcman E; Bernaudin M; Petit E
    Exp Cell Res; 2011 Oct; 317(16):2321-32. PubMed ID: 21749867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemokines in neuroectodermal tumour progression and metastasis.
    Raffaghello L; Cocco C; Corrias MV; Airoldi I; Pistoia V
    Semin Cancer Biol; 2009 Apr; 19(2):97-102. PubMed ID: 19013246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RANTES stimulates inflammatory cascades and receptor modulation in murine astrocytes.
    Luo Y; Berman MA; Zhai Q; Fischer FR; Abromson-Leeman SR; Zhang Y; Kuziel WA; Gerard C; Dorf ME
    Glia; 2002 Jul; 39(1):19-30. PubMed ID: 12112372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current status of chemokine receptor inhibitors in development.
    Allegretti M; Cesta MC; Garin A; Proudfoot AE
    Immunol Lett; 2012 Jul; 145(1-2):68-78. PubMed ID: 22698186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-faceted strategies to combat disease by interference with the chemokine system.
    Johnson Z; Schwarz M; Power CA; Wells TN; Proudfoot AE
    Trends Immunol; 2005 May; 26(5):268-74. PubMed ID: 15866240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemokines promote quiescence and survival of human neural progenitor cells.
    Krathwohl MD; Kaiser JL
    Stem Cells; 2004; 22(1):109-18. PubMed ID: 14688397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The chemokine network: a target in cancer biology?
    Slettenaar VI; Wilson JL
    Adv Drug Deliv Rev; 2006 Oct; 58(8):962-74. PubMed ID: 16996642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer stem cells and malignant gliomas. From pathophysiology to targeted molecular therapy.
    Florian IS; Tomuleasa C; Soritau O; Timis T; Ioani H; Irimie A; Kacso G
    J BUON; 2011; 16(1):16-23. PubMed ID: 21674845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemokines and cancer: migration, intracellular signalling and intercellular communication in the microenvironment.
    O'Hayre M; Salanga CL; Handel TM; Allen SJ
    Biochem J; 2008 Feb; 409(3):635-49. PubMed ID: 18177271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and anti-glioma activity of 25(R)-spirostan-3beta,5alpha,6beta,19-tetrol.
    Leng T; Zhang J; Xie J; Zhou S; Huang Y; Zhou Y; Zhu W; Yan G
    Steroids; 2010 Mar; 75(3):224-9. PubMed ID: 20026149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of an imatinib-sensitive subset of high-grade human glioma cultures.
    Hägerstrand D; Hesselager G; Achterberg S; Wickenberg Bolin U; Kowanetz M; Kastemar M; Heldin CH; Isaksson A; Nistér M; Ostman A
    Oncogene; 2006 Aug; 25(35):4913-22. PubMed ID: 16547494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The chemokine network in cancer--much more than directing cell movement.
    Kulbe H; Levinson NR; Balkwill F; Wilson JL
    Int J Dev Biol; 2004; 48(5-6):489-96. PubMed ID: 15349823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The chemokine-binding protein M3 as a tool to understand the chemokine network in vivo.
    Lira SA; Viejo-Borbolla A; Shang L; Martin AP
    Methods Enzymol; 2009; 460():193-207. PubMed ID: 19446726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.